Trial intelligence / Profile preview

CASPER: Coreg CR vs IR Compliance in Heart Failure

NCT00272805Phase 3Completed

Sponsor
Cardiovascular Clinical Sciences
Start
Oct 2005
Primary completion
Jul 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of carvedilol in chronic heart failure (CHF), sponsored by Cardiovascular Clinical Sciences. Started Oct 2005; status: completed.

02

Drugs

carvedilol
03

Conditions

chronic heart failure (CHF)

Beyond the preview

Go deeper on NCT00272805.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00272805.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call